Trial: 202003072

A Pilot Study to Assess the Safety, Feasibility, and Immunogenicity of a Neoantigen-based Personalized DNA Vaccine in Patients with Newly Diagnosed, Unmethylated Glioblastoma

Phase

I

Principal Investigator

Johanns, Tanner

Disease Site

Brain and Nervous System

Learn more about this study at: clinicaltrials.gov